J Pouchot
Overview
Explore the profile of J Pouchot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
1013
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bouyakoub L, Dinh A, Blez D, Mainardi J, Pastre J, Vassor I, et al.
Rev Med Interne
. 2024 May;
45(8):461-467.
PMID: 38719669
Introduction: Pneumonia is one of the most common indications for antibiotic. Shortening the duration of antibiotic therapy should help reduce bacterial resistance. To date, three randomized control trials have shown...
2.
3.
Daban A, Gonnin C, Phan L, Saldmann A, Granier C, Lillo-Lelouet A, et al.
Oncoimmunology
. 2023 May;
12(1):2204754.
PMID: 37187974
Introduction: Immune checkpoint inhibitors (ICIs) are now standard of care in many cancers. They can generate immune-related adverse events (irAEs), but no biomarkers are available to identify patients who are...
4.
Tennenbaum J, Volle G, Buffet P, Ranque B, Pouchot J, Arlet J
Rev Med Interne
. 2023 Jan;
44(7):335-343.
PMID: 36710088
The spleen filters blood cells and contributes to the immune defense. The red pulp clears the blood from altered red blood cells via its unique microcirculatory network ; while the...
5.
Volle G, Alexandre C, Rotenberg L, Derobertmasure A, Michon A, Flamarion E, et al.
Rev Med Interne
. 2022 Nov;
44(1):42-44.
PMID: 36335046
No abstract available.
6.
Regent A, Arlet J, Cheminet G, Pouchot J, Mouthon L, Le Jeunne C
Rev Med Interne
. 2022 Sep;
43(10):581-588.
PMID: 36089428
Introduction: During placements, there is an opportunity to learn clinical skills and to assess their application. However, it represents two different goals. The validity of an end-of-placement assessment is questionable,...
7.
Cheminet G, Mekontso-Dessap A, Pouchot J, Arlet J
Rev Med Interne
. 2022 Jul;
43(8):470-478.
PMID: 35810055
Sickle cell disease is a frequent genetic condition, due to a mutation of the β-globin gene, leading to the production of an abnormal S hemoglobin and characterized by multiple vaso-occlusive...
8.
Rambaud E, Ranque B, Pouchot J, Arlet J
Rev Med Interne
. 2022 Jun;
43(8):479-486.
PMID: 35688668
Chronic haemolysis exposes patients with sickle cell disease (SCD) to the development of black pigment gallstones, which can trigger biliary complications. In order to avoid these complications, elective cholecystectomy is...
9.
Sabatier P, Wack M, Pouchot J, Danchin N, Jannot A
BMC Med Res Methodol
. 2022 Jun;
22(1):166.
PMID: 35676635
Context: Real-life data consist of exhaustive data which are not subject to selection bias. These data enable to study drug-safety profiles but are underused because of their temporality, necessitating complex...
10.
Desbois A, Regnier P, Quiniou V, Lejoncour A, Maciejewski-Duval A, Comarmond C, et al.
Arthritis Rheumatol
. 2021 Feb;
73(7):1233-1243.
PMID: 33538119
Objective: Our aim was to compare transcriptome and phenotype profiles of CD4+ T cells and CD19+ B cells in patients with Takayasu arteritis (TAK), patients with giant cell arteritis (GCA),...